Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism
Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism
罕见病新兴团队：实现先天性代谢缺陷“三重目标”
批准号：
247573
负责人：
Potter Elizabeth K
金额：
$108.58万
依托单位：
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-08-01 至 2016-08-01
中文摘要
翻译
我们的团队提出了一项研究计划，将加拿大定位为患有罕见疾病的儿童的循证医疗保健的世界领导者，从先天性代谢错误（IEM）开始。我们有一个强大的团队，在许多学术领域的专业知识
英文摘要
Our team proposes a program of research to position Canada as a world leader in evidence-informed health care for children with rare diseases, beginning with inborn errors of metabolism (IEM). We have a strong team with expertise in many areas of academic
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An innovative registry-based trials platform to improve clinical care, outcomes, and health policy for children with treatable rare diseases
-
批准号：416065
-
项目类别：Operating Grants
-
资助金额：$200.63万
-
财政年份：2019
-
负责人：Potter Elizabeth K
-
依托单位：
Catalyzing registry-based randomized comparative effectiveness trials for inherited metabolic diseases in children: establishing a core outcome set and data collection tools
-
批准号：359015
-
项目类别：Operating Grants
-
资助金额：$7.29万
-
财政年份：2016
-
负责人：Potter Elizabeth K
-
依托单位：
Designing interventions to improve delivery of health care for children with inherited metabolic diseases: family and provider perspectives
-
批准号：357123
-
项目类别：Operating Grants
-
资助金额：$53.78万
-
财政年份：2016
-
负责人：Potter Elizabeth K
-
依托单位：
海外基金
